Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.
Inductive Bio has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Inductive Bio's investors include Andreessen Horowitz, Lux Capital, Bessemer Venture Partners, Obvious Ventures, S32.
Inductive Bio is headquartered in San Francisco, United States.
Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.
Inductive Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inductive Bio — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/inductive-bio. Accessed August 14, 2026.
VCBacked. (2025). Inductive Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/inductive-bio
{{cite web |title=Inductive Bio — Funding & Investors |url=https://www.vcbacked.co/company/inductive-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated